Rockwell Medical (RMTI +2.3%) gain today after the company signs a two-year contract with NxStage Medical (NXTM +1.8%) to manufacture dialysate concentrate for the NxStage System One. The device is the only portable hemodialysis system cleared for home use by the FDA.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs